Of note, the synthetic Bax-α5 peptide was found to trigger (when fused to a cell-penetrating peptide) caspase-dependent apoptosis of cancer cells in vitro and in vivo[41], demonstrating both the feasibility and effectiveness of this approach. The gene discussed is BAX; the disease is cancer.